Concepedia

Ruitao Lin

RL

32

Publications

1.4K

Citations

20

H-Index

2015

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Hong Kong

Bristol-Myers Squibb (United States)

Memorial Sloan Kettering Cancer Center

Simon Fraser University

Ruitao Lin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, biostatistics, and statistical inference.

Top concepts

MedicineBiostatisticsStatisticsStatistical InferenceHealthPharmacologyClinical TrialsOncologyPharmacotherapyBayesian Inference

Publications per year

2015–2024

32

Publications

32

A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients

Betül Oran, Marcos de Lima, Guillermo Garcia‐Manero et al. · Blood Advances · 2020 · 196 citations · Full text

Pharmacotherapy, Metronomic Chemotherapy, Myeloid Neoplasia +18

BOIN12: Bayesian Optimal Interval Phase I/II Trial Design for Utility-Based Dose Finding in Immunotherapy and Targeted Therapies

Ruitao Lin, Yanhong Zhou, Fangrong Yan et al. · JCO Precision Oncology · 2020 · 134 citations · Full text

Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials

Ying Yuan, Ruitao Lin, Daniel Li et al. · Clinical Cancer Research · 2018 · 122 citations · Full text

Bayesian optimal interval design for dose finding in drug-combination trials

Ruitao Lin, Guosheng Yin · Statistical Methods in Medical Research · 2015 · 94 citations

Optimal Experimental Design, Interval Designs, Markov Chain Monte Carlo +16

Time-to-event model-assisted designs for dose-finding trials with delayed toxicity

Ruitao Lin, Ying Yuan · Biostatistics · 2019 · 72 citations · Full text

Rows per page

1–5 of 32